Financials data is unavailable for this security.
View more
Year on year Indoco Remedies Ltd had net income fall -30.78% from 1.42bn to 984.60m despite a 8.91% increase in revenues from 16.69bn to 18.17bn. An increase in the selling, general and administrative costs as a percentage of sales from 40.20% to 43.37% was a component in the falling net income despite rising revenues.
| Gross margin | 68.34% |
|---|---|
| Net profit margin | 1.66% |
| Operating margin | 5.89% |
| Return on assets | 1.36% |
|---|---|
| Return on equity | 2.97% |
| Return on investment | 1.99% |
More ▼
Cash flow in INRView more
In 2024, Indoco Remedies Ltd increased its cash reserves by 35.98%, or 39.31m. Cash Flow from Financing totalled 2.80bn or 15.43% of revenues. In addition the company generated 1.57bn in cash from operations while cash used for investing totalled 4.34bn.
| Cash flow per share | 13.47 |
|---|---|
| Price/Cash flow per share | 21.78 |
| Book value per share | 118.23 |
|---|---|
| Tangible book value per share | 97.99 |
More ▼
Balance sheet in INRView more
| Current ratio | 1.29 |
|---|---|
| Quick ratio | 0.8142 |
| Total debt/total equity | 0.7658 |
|---|---|
| Total debt/total capital | 0.4339 |
More ▼
Growth rates in INR
Year on year, both dividends per share and earnings per share excluding extraordinary items growth dropped -33.33% and -30.79%, respectively. Additionally, five year annualized dividend per share growth ranks above the industry average relative to its peers.
| Div yield(5 year avg) | 0.46% |
|---|---|
| Div growth rate (5 year) | 37.97% |
| Payout ratio (TTM) | 43.16% |
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -72.82 |
More ▼
